Updated Aug 6 at 2:20pm ET.
Follow DuPont to never miss an important update.
Federal Reserve officials are weighing whether the rapid pace of investment in AI data centers is becoming excessive. They are concerned that this frenzied spending could create risks for the broader financial system if the expected returns do not materialize.
This matters for DuPont because its electronics business is a major supplier of materials used to make the advanced chips that power AI. If big tech companies pull back on data center spending, it could slow the recovery in chip manufacturing volumes that DuPont is counting on for growth.
Source: Reuters
DuPont won a 2026 R&D 100 Award for its Liveo Pharma TPE tubing, which is designed for biopharmaceutical processing at extremely low temperatures. These awards recognize the top 100 technical innovations of the year. While a single award does not change the company's value, it highlights DuPont's focus on high-margin healthcare materials. This segment is a key part of the company's shift toward specialized chemistry that is difficult for rivals to replicate.
Source: PRNewsWire
The company's specialized water membrane was recognized for helping industrial plants reuse water and recover resources from brine, which is highly salty wastewater. This technology reduces the energy needed for traditional water treatment. Water filtration is one of DuPont's most important growth areas. As global regulations on industrial waste tighten and water becomes scarcer, demand for these high-efficiency membranes provides a steady, less cyclical source of profit compared to the company's older chemical businesses.
Source: PRNewsWire
UBS raised its price target for DuPont from $175 to $178. This small adjustment reflects the firm's continued confidence in the stock after DuPont reported earnings that exceeded expectations. While the target change is minor, it signals that analysts see the company's pivot toward semiconductor and water materials as on track. The stock currently trades well below this target, suggesting the firm believes there is significant room for the price to rise as the electronics market recovers.
Source: UBS
DuPont earned $1.88 per share last quarter, beating the $1.76 analysts expected. Sales rose 4 percent to $1.8 billion as the company saw growth across its main business segments. Management was confident enough in the results to raise its financial goals for the rest of the year.
The company also plans to spend $250 million buying back its own shares in the third quarter. This is a sign that DuPont is generating plenty of cash as it completes its transition into a focused materials company. By reducing the number of shares available, buybacks can help increase the value of each remaining share for long-term owners.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
The company has cleared the bar eight quarters in a row, often by a wide margin. This suggests management is conservative with its forecasts and the business is performing reliably.
| Expectation | |
|---|---|
| EPS | $1.90 |
| Revenue | $1.86B |
